Homocystine, atherosclerosis and thrombosis: implications for oral contraceptive users.
D000592:Amino Acid Metabolism, Inborn Errors; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D002648:Child; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology; D004617:Embolism / Q000209:etiology; D005260:Female; D005947:Glucose / Q000378:metabolism; D006710:Homocysteine / Q000097:blood / Q000378:metabolism; D006711:Homocystine / Q000378:metabolism*; D006712:Homocystinuria; D006801:Humans; D006836:Hydro-Lyases / Q000378:metabolism; D006949:Hyperlipidemias / Q000139:chemically induced; D008715:Methionine / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology*
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D006710:Homocysteine; D006711:Homocystine; D008715:Methionine; D006836:Hydro-Lyases; D005947:Glucose